1. U.S. Food & Drug Adminstartion, YESCARTA (axicabtagene ciloleucel), Product information
2. European Medicines Agency, Zalmoxis (Allogeneic T cells genetically modified with a retroviral vector encoding for a truncated form of the human low affinity nerve growth factor receptor (DLNGFR) and the herpes simplex I virus thymidine kinase (HSV-TK Mut2)), Product Information
3. European Medicines Agency, Strimvelis (autologous CD34+ enriched cell fraction that contains CD34+ cells transduced with retroviral vector that encodes for the human ADA cDNA sequence), Product information
4. U.S. Food & Drug Adminstration, KYMRIAH (tisagenlecleucel), product information
5. Adoptive therapy with CAR redirected T cells: the challenges in targeting solid tumors;Abken;Immunotherapy,2015